Correlation Between Samsung Biologics and Iljin Materials

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and Iljin Materials at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and Iljin Materials into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Biologics Co and Iljin Materials Co, you can compare the effects of market volatilities on Samsung Biologics and Iljin Materials and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of Iljin Materials. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and Iljin Materials.

Diversification Opportunities for Samsung Biologics and Iljin Materials

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Samsung and Iljin is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and Iljin Materials Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iljin Materials and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with Iljin Materials. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iljin Materials has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and Iljin Materials go up and down completely randomly.

Pair Corralation between Samsung Biologics and Iljin Materials

Assuming the 90 days trading horizon Samsung Biologics Co is expected to generate 0.41 times more return on investment than Iljin Materials. However, Samsung Biologics Co is 2.43 times less risky than Iljin Materials. It trades about -0.01 of its potential returns per unit of risk. Iljin Materials Co is currently generating about -0.24 per unit of risk. If you would invest  100,000,000  in Samsung Biologics Co on September 15, 2024 and sell it today you would lose (1,400,000) from holding Samsung Biologics Co or give up 1.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Samsung Biologics Co  vs.  Iljin Materials Co

 Performance 
       Timeline  
Samsung Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Samsung Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Samsung Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Iljin Materials 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iljin Materials Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Samsung Biologics and Iljin Materials Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Samsung Biologics and Iljin Materials

The main advantage of trading using opposite Samsung Biologics and Iljin Materials positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, Iljin Materials can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iljin Materials will offset losses from the drop in Iljin Materials' long position.
The idea behind Samsung Biologics Co and Iljin Materials Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios